Profile | GDS2987 / GI_13929471-S |
Title | Comparison of Rho kinase inhibitor and atorvastatin effects on primary cell lines |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM214810 | HMVEC_vehicle_rep1 | 46.4 | 70 |
GSM215244 | HMVEC_vehicle_rep2 | 54.1 | 70 |
GSM215253 | HMVEC_vehicle_rep3 | 67.4 | 73 |
GSM215254 | HMVEC_atorvastatin_rep1 | 101.7 | 76 |
GSM215282 | HMVEC_atorvastatin_rep3 | 79 | 73 |
GSM215344 | HMVEC_atorvastatin_rep2 | 55.7 | 70 |
GSM215283 | HMVEC_atorvastatin_mevalonate_rep1 | 5 | 10 |
GSM215284 | HMVEC_atorvastatin_mevalonate_rep2 | 48.3 | 64 |
GSM215293 | HMVEC_atorvastatin_mevalonate_rep3 | 25 | 39 |
GSM215294 | HMVEC_SLx2119_rep1 | 96.2 | 76 |
GSM215295 | HMVEC_SLx2119_rep2 | 27 | 47 |
GSM215296 | HMVEC_SLx2119_rep3 | 44.4 | 58 |
GSM215297 | PASMC_vehicle_rep1 | 22.3 | 33 |
GSM215298 | PASMC_vehicle_rep2 | 2.8 | 5 |
GSM215310 | PASMC_vehicle_rep3 | 8.1 | 13 |
GSM215311 | PASMC_atorvastatin_rep1 | 4.4 | 8 |
GSM215312 | PASMC_atorvastatin_rep2 | 10.3 | 17 |
GSM215313 | PASMC_atorvastatin_rep3 | ||
GSM215324 | PASMC_atorvastatin_mevalonate_rep1 | 40 | 55 |
GSM215325 | PASMC_atorvastatin_mevalonate_rep2 | 36.5 | 56 |
GSM215326 | PASMC_atorvastatin_mevalonate_rep3 | 26.7 | 42 |
GSM215327 | PASMC_SLx2119_rep1 | 44.7 | 59 |
GSM215328 | PASMC_SLx2119_rep2 | 34.6 | 52 |
GSM215329 | PASMC_SLx2119_rep3 | 39.4 | 58 |
GSM215330 | Fibroblasts_vehicle_rep1 | ||
GSM215331 | Fibroblasts_vehicle_rep2 | ||
GSM215332 | Fibroblasts_vehicle_rep3 | 16.2 | 46 |
GSM215333 | Fibroblasts_atorvastatin_rep1 | ||
GSM215334 | Fibroblasts_atorvastatin_rep2 | 8.9 | 25 |
GSM215335 | Fibroblasts_atorvastatin_rep3 | ||
GSM215336 | Fibroblasts_atorvastatin_mevalonate_rep1 | 8.6 | 28 |
GSM215337 | Fibroblasts_atorvastatin_mevalonate_rep2 | 17.7 | 49 |
GSM215338 | Fibroblasts_atorvastatin_mevalonate_rep3 | ||
GSM215339 | Fibroblasts_SLx2119_rep1 | 3.6 | 11 |
GSM215340 | Fibroblasts_SLx2119_rep2 | ||
GSM215341 | Fibroblasts_SLx2119_rep3 |